Last10K.com

Oncolytics Biotech Inc (ONCY) SEC Filing 20-F Annual report for the fiscal year ending Monday, December 31, 2018

Oncolytics Biotech Inc

HISTORY TOOLS
CIK: 1129928 Ticker: ONCY

View differences made from one year to another to evaluate Oncolytics Biotech Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 20-F Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Oncolytics Biotech Inc.

Continue

Assess how Oncolytics Biotech Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Oncolytics Biotech Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 20-F Annual Report

Document And Entity Information Document
Consolidated Statements Of Cash Flows
Consolidated Statements Of Changes In Equity
Consolidated Statements Of Financial Position
Consolidated Statements Of Financial Position (Parenthetical)
Consolidated Statements Of Loss And Comprehensive Loss
Additional Cash Flow Disclosures
Additional Cash Flow Disclosures (Tables)
Additional Cash Flow Disclosures - Net Change In Non-Cash Working Capital (Details)
Additional Cash Flow Disclosures - Other Cash Flow Disclosures (Details)
Basis Of Financial Statement Presentation
Capital Disclosures
Capital Disclosures (Details)
Capital Disclosures (Tables)
Cash Equivalents
Cash Equivalents - Narrative (Details)
Commitments
Commitments (Details)
Commitments (Tables)
Contingencies
Contingencies (Details)
Contract Liability And Receivable
Contract Liability And Receivable (Tables)
Contract Liability And Receivable - Narrative (Details)
Contract Liability And Receivable - Schedule Of Contract Revenues And Liabilities (Details)
Economic Dependence
Economic Dependence (Details)
Financial Instruments
Financial Instruments (Tables)
Financial Instruments - Narrative (Details)
Financial Instruments - Schedule Of Balances In Foreign Currencies (Details)
Income Taxes
Income Taxes (Tables)
Income Taxes - Provision For Income Taxes (Details)
Income Taxes - Schedule Of Unrecognized Deferred Tax Assets (Details)
Income Taxes - Summary Of Non-Capital Losses (Details)
Income Taxes - Summary Of Non-Refundable Federal Investment Tax Credits (Details)
Incorporation And Nature Of Operations
Indemnification Of Officers And Directors
Loss Per Common Share
Loss Per Common Share (Details)
Other Expenses And Adjustments
Other Expenses And Adjustments (Details)
Other Expenses And Adjustments (Tables)
Property And Equipment
Property And Equipment (Details)
Property And Equipment (Tables)
Related Party Transactions
Related Party Transactions (Details)
Related Party Transactions (Tables)
Share Based Payments
Share Based Payments (Tables)
Share Based Payments - Disclosure Weighted Average Assumptions And Fair Value Of Options (Details)
Share Based Payments - Narrative (Details)
Share Based Payments - Schedule Of Number Of Other Equity Instruments (Details)
Share Based Payments - Schedule Of Stock Options And Weighted Average Exercise Prices (Details)
Share Based Payments - Schedule Of Stock Options Outstanding And Exercisable By Range Of Exercise Price (Details)
Share Capital
Share Capital (Tables)
Share Capital - Narrative (Details)
Share Capital - Schedule Of Share Capital (Details)
Share Capital - Schedule Of Share Capital Footnotes (Details)
Share Capital - Summary Of Outstanding Warrants (Details)
Significant Judgments, Estimates And Assumptions
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (Policies)
Summary Of Significant Accounting Policies (Tables)
Summary Of Significant Accounting Policies - Narrative (Details)
Summary Of Significant Accounting Policies - Schedule Of Depreciation Rates (Details)
Ticker: ONCY
CIK: 1129928
Form Type: 20-F Annual Report
Accession Number: 0001129928-19-000014
Submitted to the SEC: Fri Mar 15 2019 5:21:25 PM EST
Accepted by the SEC: Fri Mar 15 2019
Period: Monday, December 31, 2018
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/oncy/0001129928-19-000014.htm